Skip to content
Stay updated with the latest gaming news, reviews, and tips…

Zimbabwe Declines ‘Unbalanced’ American Health Aid Agreement Because of Information Fears

Health funding illustration
The proposed American financial assistance would have supported programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has rejected a significant American health deal worth 367 million US dollars (£272m) over five years due to Washington's insistence on sensitive information.

This move came to light following a official document from December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".

An official spokesperson later explained that the United States was seeking biological samples for research and commercial purposes but refused to share the benefits from any future medical innovations.

"We are forced to start the difficult and regrettable task of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the United States had donated more than $1.9bn in health funding to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has urged continued talks to reach a deal agreeable to all parties so the country's critical HIV programme can continue.

Wider Background

This development comes after a similar situation in neighbouring Kenya, where a court suspended a related deal with the US following legal challenges were filed about the security of citizens' health data.

After resuming office recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

The agency had overseen assistance for the US government, but Trump argued its expenditure was "inefficient" and his government was pursuing government-to-government deals to enhance openness and accountability.

As per statements, Sixteen African countries have so far agreed to these new health pacts, constituting over $18.3bn in committed funds.

Details of the Declined Agreement

The funds for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this partnership would have delivered significant advantages for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy through US-supported initiatives," the Ambassador added.

However, official spokesman Nick Mangwana said the proposed deal was "unequal".

"Our nation was requested to provide its biological resources and data for a long time, without any equivalent assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.

"Put simply, our country would supply the basic resources for scientific discovery without any certainty that the end products would be available to our citizens should a new pandemic emerge."

Sovereignty and International Frameworks

He also pointed out that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting systems previously set up through the international organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to deal with potential global health emergencies.

"This system is designed to ensure that when a country contributes its data, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised solely by those with the resources to develop them."

The government's concerns regarding the US deal "are not meant as opposition to America," Mangwana stressed.

"We are open to continued discussions with our American counterparts on how future co-operation could be arranged in a way that honours the independence and interests of both nations."

Medical Community Reaction

Medical experts said it understood the government's concerns, but suggested that talks should continue considering a large portion of the nation's Aids initiatives depended on international support.

"In cases where specific concerns arise, such as those relating to data governance or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," the group commented.

The halted deal highlights the continuing challenges between accepting crucial foreign assistance and safeguarding national sovereignty in an ever more data-driven world.

Written by

Steven Gibbs

Liam Voss is a seasoned gaming journalist with a passion for uncovering hidden gems and analyzing industry trends.

Gamma Arena Daily

Type to search articles.